Hinge Health, Inc.
HNGENYSEHealthcare● Active
$63.46
$-0.17(-0.26%)
Market Cap$4.9B
P/E Ratio—
52W High$65.7189
52W Low$30.08
Hinge Health, Inc. (HNGE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HNGE · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.45
Est. $0.39 · +15.4%
Revenue
$0.18B
Est. $0.17B · +5.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 4-Quarter EPS Beat Streak
HNGE reports quarterly as a NYSE-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 4, 2026 | $0.60 | — | — | — | $0.19B | — |
| ▲ Q2 FY2026 | May 5, 2026 | $0.39 | $0.45 | +15.4% | $0.18B | $0.17B | +5.9% |
| ▲ Q1 FY2026 | Feb 10, 2026 | $0.04 | $0.49 | +1125.0% | $0.17B | $0.16B | +9.0% |
| ▲ Q4 FY2025 | Nov 4, 2025 | $0.24 | $0.34 | +41.7% | $0.15B | $0.16B | -1.6% |
| ▲ Q3 FY2025 | Aug 5, 2025 | $0.09 | $0.67 | +644.4% | $0.14B | $0.13B | +5.0% |
| — Q2 FY2025 | May 5, 2025 | — | $0.21 | — | $0.12B | — | — |
Q3 FY2026
Aug 4, 2026
EPS Actual
—
EPS Est.
$0.60
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
$0.45
EPS Est.
$0.39
EPS Surpr.
+15.4%
Revenue
$0.18B
Q1 FY2026
Feb 10, 2026Beat
EPS Actual
$0.49
EPS Est.
$0.04
EPS Surpr.
+1125.0%
Revenue
$0.17B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
$0.34
EPS Est.
$0.24
EPS Surpr.
+41.7%
Revenue
$0.15B
Q3 FY2025
Aug 5, 2025Beat
EPS Actual
$0.67
EPS Est.
$0.09
EPS Surpr.
+644.4%
Revenue
$0.14B
Q2 FY2025
May 5, 2025
EPS Actual
$0.21
EPS Est.
—
EPS Surpr.
—
Revenue
$0.12B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.10 | $1.14 | $1.16 | 4 |
| Q3 FY2028 | $1.07 | $1.11 | $1.13 | 6 |
| Q2 FY2028 | $1.06 | $1.10 | $1.12 | 4 |
| Q1 FY2028 | $0.97 | $1.01 | $1.03 | 4 |
| Q4 FY2027 | $0.89 | $0.93 | $0.95 | 3 |
| Q3 FY2027 | $0.79 | $0.82 | $0.84 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.3B | $0.3B | $0.3B | 3 |
| Q3 FY2028 | $0.3B | $0.3B | $0.3B | 5 |
| Q2 FY2028 | $0.3B | $0.3B | $0.3B | 3 |
| Q1 FY2028 | $0.3B | $0.3B | $0.3B | 3 |
| Q4 FY2027 | $0.3B | $0.3B | $0.3B | 4 |
| Q3 FY2027 | $0.2B | $0.2B | $0.2B | 5 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +15.4% | $48.89 | $49.75 | +1.76% |
| ▲ Q1 FY2026 | Feb 10, 2026 | +1125.0% | $32.16 | $32.98 | +2.55% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +41.7% | $50.34 | $53.44 | +6.16% |
| ▲ Q3 FY2025 | Aug 5, 2025 | +644.4% | $48.22 | $48.22 | +0.00% |
| — Q2 FY2025 | May 5, 2025 | — | No price data | $37.56 | — |
Q2 FY2026+1.76%
Report Date
May 5, 2026
EPS Beat/Miss
+15.4%
Price Before
$48.89
Price After
$49.75
Q1 FY2026+2.55%
Report Date
Feb 10, 2026
EPS Beat/Miss
+1125.0%
Price Before
$32.16
Price After
$32.98
Q4 FY2025+6.16%
Report Date
Nov 4, 2025
EPS Beat/Miss
+41.7%
Price Before
$50.34
Price After
$53.44
Q3 FY2025+0.00%
Report Date
Aug 5, 2025
EPS Beat/Miss
+644.4%
Price Before
$48.22
Price After
$48.22
Q2 FY2025—
Report Date
May 5, 2025
EPS Beat/Miss
—
Price Before
—
Price After
$37.56
Avg Beat Reaction+2.62%
Beat Rate4 / 5 quarters
Largest Move+6.16% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HNGE ends December
Hinge Health, Inc. (HNGE) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.45 — beating the analyst consensus of $0.39 by +15.4%. HNGE has beaten EPS estimates for 4 consecutive quarters. The next HNGE earnings date is expected around September 1, 2026.
Each quarter, investors track HNGE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HNGE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HNGE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HNGE earnings · 5 questionsHinge Health, Inc.'s next earnings report is expected around September 1, 2026. HNGE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HNGE historically reports after market close (AMC).
HNGE earnings datewhen is HNGE earningsHNGE next earnings datewhen does HNGE report earningsHNGE earnings calendar
▸ Source: FMP · Hinge Health, Inc. SEC filings · US GAAP · Hinge Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026